PT86232A - Process for preparing a pharmaceutical composition containing a9-substituted guanine - Google Patents
Process for preparing a pharmaceutical composition containing a9-substituted guanineInfo
- Publication number
- PT86232A PT86232A PT86232A PT8623287A PT86232A PT 86232 A PT86232 A PT 86232A PT 86232 A PT86232 A PT 86232A PT 8623287 A PT8623287 A PT 8623287A PT 86232 A PT86232 A PT 86232A
- Authority
- PT
- Portugal
- Prior art keywords
- preparing
- pharmaceutical composition
- composition containing
- substituted guanine
- interferon
- Prior art date
Links
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 title 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000014150 Interferons Human genes 0.000 abstract 1
- 108010050904 Interferons Proteins 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- -1 phosphate ester Chemical class 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Formation And Processing Of Food Products (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868628826A GB8628826D0 (en) | 1986-12-02 | 1986-12-02 | Pharmaceutical products |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT86232A true PT86232A (en) | 1987-12-01 |
| PT86232B PT86232B (pt) | 1990-11-07 |
Family
ID=10608331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT86232A PT86232B (pt) | 1986-12-02 | 1987-11-27 | Processo para a preparacao de uma composicao farmaceutica contendo uma guanina 9-substituida |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4957733A (pt) |
| EP (1) | EP0271270B1 (pt) |
| JP (1) | JP2724711B2 (pt) |
| KR (1) | KR960000432B1 (pt) |
| AT (1) | ATE74011T1 (pt) |
| AU (1) | AU606629B2 (pt) |
| CA (1) | CA1318850C (pt) |
| DE (1) | DE3777769D1 (pt) |
| DK (1) | DK166715B1 (pt) |
| ES (1) | ES2037095T3 (pt) |
| GB (1) | GB8628826D0 (pt) |
| GR (1) | GR3004487T3 (pt) |
| IE (1) | IE59943B1 (pt) |
| NZ (1) | NZ222741A (pt) |
| PT (1) | PT86232B (pt) |
| ZA (1) | ZA878983B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8813032D0 (en) * | 1988-06-02 | 1988-07-06 | Boehringer Ingelheim Int | Antiviral pharmaceutical composition |
| EP0405315B1 (en) * | 1989-06-30 | 1995-08-23 | American Cyanamid Company | Use of a phagocyte-activating agent : LPS or IL-2 for the manufacture of a medicament for treating staphylococcus aureus infection in cows |
| JPH03124960A (ja) * | 1989-10-11 | 1991-05-28 | Mitsubishi Electric Corp | 同軸形スタータ装置 |
| GB9015051D0 (en) * | 1990-07-07 | 1990-08-29 | Beecham Group Plc | Pharmaceutical treatment |
| US6124304A (en) * | 1993-10-05 | 2000-09-26 | Smithkline Beecham Plc | Penciclovir for the treatment of zoster associated pain |
| GB9326177D0 (en) * | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Pharmaceuticals |
| GB9323404D0 (en) * | 1993-11-12 | 1994-01-05 | Smithkline Beecham Plc | Pharmaceuticals |
| GB9615111D0 (en) * | 1996-07-18 | 1996-09-04 | Smithkline Beecham Plc | Pharmaceuticals |
| AU5127098A (en) * | 1996-11-29 | 1998-06-22 | Smithkline Beecham Plc | Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis |
| RU2148988C1 (ru) * | 1997-07-21 | 2000-05-20 | Самойленко Игорь Иннокентьевич | Усовершенствованная лекарственная форма человеческого интерферона-свеча |
| US6165458A (en) * | 1997-12-26 | 2000-12-26 | Pharmaderm Laboratories Ltd. | Composition and method for dermal and transdermal administration of a cytokine |
| EP1655813A1 (de) * | 2004-11-09 | 2006-05-10 | Phoenix Contact GmbH & Co. KG | Befestigung für elektrische Verbindung |
| AU2006230269A1 (en) | 2005-03-30 | 2006-10-05 | Novartis Ag | Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4461757A (en) * | 1983-02-23 | 1984-07-24 | Ens Bio Logicals Inc. | Dimethylaminomethylenated anti-herpes compounds |
| DE3485225D1 (de) * | 1983-08-18 | 1991-12-05 | Beecham Group Plc | Antivirale guanin-derivate. |
| EP0182024B1 (en) * | 1984-09-20 | 1991-04-03 | Beecham Group Plc | Purine derivatives and their pharmaceutical use |
| US4606917A (en) * | 1984-10-03 | 1986-08-19 | Syntex (U.S.A) Inc. | Synergistic antiviral composition |
-
1986
- 1986-12-02 GB GB868628826A patent/GB8628826D0/en active Pending
-
1987
- 1987-11-27 PT PT86232A patent/PT86232B/pt unknown
- 1987-11-30 EP EP87310550A patent/EP0271270B1/en not_active Expired - Lifetime
- 1987-11-30 US US07/126,406 patent/US4957733A/en not_active Expired - Lifetime
- 1987-11-30 CA CA000553128A patent/CA1318850C/en not_active Expired - Lifetime
- 1987-11-30 DK DK627987A patent/DK166715B1/da not_active IP Right Cessation
- 1987-11-30 IE IE324787A patent/IE59943B1/en not_active IP Right Cessation
- 1987-11-30 ZA ZA878983A patent/ZA878983B/xx unknown
- 1987-11-30 NZ NZ222741A patent/NZ222741A/xx unknown
- 1987-11-30 DE DE8787310550T patent/DE3777769D1/de not_active Expired - Lifetime
- 1987-11-30 AT AT87310550T patent/ATE74011T1/de not_active IP Right Cessation
- 1987-11-30 AU AU81912/87A patent/AU606629B2/en not_active Expired
- 1987-11-30 ES ES198787310550T patent/ES2037095T3/es not_active Expired - Lifetime
- 1987-12-01 JP JP62304412A patent/JP2724711B2/ja not_active Expired - Lifetime
- 1987-12-01 KR KR1019870013711A patent/KR960000432B1/ko not_active Expired - Lifetime
-
1992
- 1992-05-05 GR GR920400845T patent/GR3004487T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR880007080A (ko) | 1988-08-26 |
| ATE74011T1 (de) | 1992-04-15 |
| AU606629B2 (en) | 1991-02-14 |
| DK627987D0 (da) | 1987-11-30 |
| ZA878983B (en) | 1988-08-31 |
| EP0271270B1 (en) | 1992-03-25 |
| JP2724711B2 (ja) | 1998-03-09 |
| CA1318850C (en) | 1993-06-08 |
| PT86232B (pt) | 1990-11-07 |
| GR3004487T3 (pt) | 1993-03-31 |
| JPS63145279A (ja) | 1988-06-17 |
| DK627987A (da) | 1988-06-03 |
| DE3777769D1 (de) | 1992-04-30 |
| EP0271270A2 (en) | 1988-06-15 |
| NZ222741A (en) | 1990-10-26 |
| US4957733A (en) | 1990-09-18 |
| IE59943B1 (en) | 1994-05-04 |
| KR960000432B1 (ko) | 1996-01-06 |
| DK166715B1 (da) | 1993-07-05 |
| EP0271270A3 (en) | 1989-09-27 |
| AU8191287A (en) | 1988-06-02 |
| ES2037095T3 (es) | 1993-06-16 |
| IE873247L (en) | 1988-06-02 |
| GB8628826D0 (en) | 1987-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT53368A (en) | Process for producing pyrazolo-pyridine derivatives and pharmaceutical compositions containing them | |
| HU9008407D0 (en) | Process for the production of purine nucleoside derivatives and medical preparations containing them as active agents | |
| HUT44081A (en) | Process for producing avermectin derivatives and pharmaceutical compositions containing them as active components | |
| AU3502289A (en) | Method for administering the drug deprenyl so as to minimize the danger of side effects | |
| ZA928170B (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid | |
| NZ237936A (en) | 2-deoxy-neuraminic acid derivatives & analogs; antiviral medicaments | |
| HUT46657A (en) | Process for producing antitumour pharmaceutical compositions comprising sulfonyl-urea derivatives as active ingredient | |
| PT85551A (en) | Process for the preparation of antiviral pyrimidine derivatives and of pharmaceutical compositions containing the same | |
| HUT48247A (en) | Process for producing aza-bicyclo-octyl-ether derivatives and pharmaceutical compositions containing them as active components | |
| PT86232A (en) | Process for preparing a pharmaceutical composition containing a9-substituted guanine | |
| PT86516A (en) | Process for the preparation of heteroaryl-3-oxo-propani-nitrile derivatives and of pharmaceutical compositions containing the same | |
| HUT49367A (en) | Process for producing aristeromycin/adenosine derivatives and pharmaceutical compositions comprising same as active ingredient | |
| FI93106C (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi | |
| HUT48251A (en) | Process for producing new xantin derivatives and pharmaceutical compositions containing them as active components | |
| HU896190D0 (en) | Process for the preparation of pharmaceutical compositions containing pyrazole derivatives | |
| FI895983A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi | |
| EP0315316A3 (en) | Imidazole derivatives, process and intermediates for their preparation, pharmaceutical compositions containing them and their pharmaceutical use | |
| HUT43848A (en) | Process for producing pyridinyl-piperazine derivatives and pharmaceutical compositions containing them as active agents | |
| HUT53522A (en) | Process for producing pharmaceutical compositions comprising purine derivatives | |
| HUT45249A (en) | Process for producing 6,7,8,9-tetrahydro-10-methylpyrido/1,2-a/indol-9-amines, theyr derivatives and pharmaceutical compositions containing them as active components | |
| HUT51632A (en) | Process for producing derivatives of alkyl-phospho- and phosphono-serine as well as pharmaceutical preparations containing such compounds | |
| PT88681A (pt) | A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives | |
| HU895952D0 (en) | Process for the preparation of substituted pyrrolidone-2-carboxylic acid derivatives and pharmaceutical compositions containing them | |
| IE873212L (en) | Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor | |
| ZA891413B (en) | Derivatives of 1-arylsulfonyl-2-pyrrolidinone,process for their preparation and intermediates thus obtained,their use as medicaments and compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC3A | Transfer or assignment |
Free format text: 20011115 NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. BM |
|
| TE3A | Change of address (patent) |
Owner name: BEECHAM GROUP P.L.C. Effective date: 20011115 |